944718-31-4 (5-溴-1-甲基-1H-苯并[d][1,2,3]三唑,5-bromo-1-methyl-1H-1,2,3-benzotriazole)

CAS号:
944718-31-4
中文名称:
5-溴-1-甲基-1H-苯并[d][1,2,3]三唑
英文名称:
5-bromo-1-methyl-1H-1,2,3-benzotriazole
分子式:
C7H6BrN3
分子量:
212.046639919281

5-溴-1-甲基-1H-苯并[d][1,2,3]三唑(944718-31-4)名称与标识符

名称

中文别名:
5-溴-1-甲基-1H-苯并[d][1,2,3]三唑;
英文别名:
5-bromo-1-methylbenzotriazole;5-Bromo-1-methyl-1H-benzo[d][1,2,3]triazole;5-bromo-1-methyl-1H-1,2,3-benzotriazole;AS06400;CM10633;AK151549;5-BROMO-1-METHYL-1,2,3-BENZOTRIAZOLE;Z1966565729;5-Bromo-1-methyl-1H-benzotriazole (ACI);

标识符

MDL:
MFCD19288764
InChIKey:
PPUYITCIMJVKFE-UHFFFAOYSA-N
Inchi:
1S/C7H6BrN3/c1-11-7-3-2-5(8)4-6(7)9-10-11/h2-4H,1H3
SMILES:
BrC1C=C2N=NN(C2=CC=1)C

5-溴-1-甲基-1H-苯并[d][1,2,3]三唑(944718-31-4)物化性质

实验特性

  • 溶解度 : Very 微溶 (0.85 g/L) (25 ºC),
  • 密度 : 1.76±0.1 g/cm3 (20 ºC 760 Torr),

计算特性

  • 氢键供体数量 : 0
  • 氢键受体数量 : 2
  • 可旋转化学键数量 : 0
  • 重原子数量 : 11
  • 复杂度 : 153
  • 疏水参数计算参考值(XlogP) : 1.8
  • 拓扑分子极性表面积 : 30.7

5-溴-1-甲基-1H-苯并[d][1,2,3]三唑(944718-31-4)推荐厂家 更多厂家(16)

5-溴-1-甲基-1H-苯并[d][1,2,3]三唑(944718-31-4)合成路线

合成路线:1 步
反应条件:
参考文献:
Aerobic Electrochemical Csp3-N Coupling between Aliphatic Carboxylic Acids and N-heterocycles
Chen, Ruonan; Yuan, Hongyan; Wang, Yawen ; Chen, Hongyu ; Zhang, Yanhua, Organometallics, 2023, 42(1), 1-5
合成路线:1 步
反应条件:
参考文献:
Preparation of propionic acids containing 5-substituted tetrahydroisoquinoline and its application for treating or alleviating inflammatory disease
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of quinoxaline-6-carboxylic acid derivatives as modulators of PAS kinase
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Pyrazole derivatives as KDM1A inhibitors for the treatment of disease and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1, and method for cancer treatment
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Antitumor effect potentiator comprising biphenyl compound having LSD1-inhibiting activity for combination therapy
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Preparation of novel biphenyl compounds or salts thereof as lysine specific demethylase 1 (LSD1) inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Substituted quinoxaline derivatives as PFKFB3 inhibitors and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Hydantoin derivatives for the treatment of inflammatory disorders and their preparation
, World Intellectual Property Organization, , ,